Key Highlights
- Jin Medical International (NASDAQ:ZJYL) lost 17.7% to USD 3.25 from a computed prior close of USD 3.95, wiping out Monday's USD 0.59 gain, or 17.6%, with a Market Value near USD 25.44 million, computed.
- Frontier Nuclear and Minerals (NASDAQ:FNUC) dropped 14.44% to USD 0.66 from a computed USD 0.7714. Founder Group (NASDAQ:FGL) fell 14.39% to USD 1.19 from a computed USD 1.39.
- Yueda Digital (NASDAQ:YDKG) declined 13.36% to USD 0.90, implying a market value near USD 4.98 million. Oxbridge Re (NASDAQ:OXBR) retreated 11.74% to USD 0.79, near USD 6.4 million. Both sit below the USD 1.00 Nasdaq minimum bid.
- Nothing dated November 9 or 10, 2026 ties any of the five names to news, so the light-volume slides look more like profit-taking, dilution worries or small-cap swings.
Jin Medical International (NASDAQ:ZJYL): 17.7% Lower Pre-Market, No Known Trigger
Jin Medical International (NASDAQ:ZJYL) was indicated at USD 3.25 before the Tuesday open on November 10, 2026, down 17.7% from a computed prior close of USD 3.95, a fall of USD 0.70 per share. The prior session gained USD 0.59, or 17.6%, which puts the prior close near USD 3.36 and means the pre-market quote more than erases that gain. Published coverage dated November 9 or 10 identifies no trigger. Recent company news covered wheelchair provision for the 12th Jiangsu Provincial Games for Persons with Disabilities, plus displays at four worldwide industry expos. Monday's close valued the company at USD 30.92 million across 7,827,355 shares; at USD 3.25 the computed figure is about USD 25.44 million. Revenue is USD 19.73 million, which gives a price-to-sales ratio near 1.29, computed. The 52-week range runs from USD 1.53 to USD 5.68, and the Debt-to-Equity Ratio is 0.85. A 1-for-20 consolidation has left the float slim, meaning a handful of trades could shift ZJYL, and a turnaround is possible.
Frontier Nuclear and Minerals (NASDAQ:FNUC): 14.44% Lower Pre-Market, No Known Trigger
Frontier Nuclear and Minerals (NASDAQ:FNUC) was quoted at USD 0.66 before the Tuesday session on November 10, 2026, down 14.44% from a computed prior close of USD 0.7714, a drop of USD 0.1114 per share. Two searches found no release, filing, offering or analyst action dated November 9 or 10. The company, previously Snow Lake Resources, altered its name and symbol effective March 16, 2026. A published page shows market value at USD 40.27 million, yet 18.03 million shares at USD 0.66 produce a computed USD 11.90 million; the two numbers conflict. The 52-week range of USD 2.234 to USD 10.380 comes from a March 16 snapshot and is out of date. At USD 0.66 the quote sits 34.0% beneath the USD 1.00 minimum bid, and a deficiency notice is triggered after 30 consecutive Business days below that level. Trailing net loss stood at USD 11.72 million, the firm reports a single employee and no revenue, so share issuance could dilute existing holders. Only a handful of trades may push FNUC around, and spreads may be broad.
Founder Group (NASDAQ:FGL): 14.39% Lower Pre-Market, No Known Trigger
Founder Group Limited (NASDAQ:FGL) was quoted at USD 1.19 before the Tuesday session on November 10, 2026, down 14.39% from a computed prior close of USD 1.39, a decline of USD 0.20 per share. Searches surfaced nothing dated November 9 or 10 from the company, in filings or from analysts. An October 26 snapshot had USD 1.79 on 2,000,261 shares of volume; the present quote sits 33.5% lower, computed, while the October 30 close of USD 1.35 fell 8.78%. A 100-for-1 share combination announced on August 27, 2026 may have left the float thin. The Malaysian solar builder posted 2025 revenue of 120.70 million ringgit against a loss of 7.76 million ringgit. Trailing revenue reached USD 29.73 million, up 33.6%, and the trailing net loss was USD 1.91 million. One page listing 11.46 thousand shares looks like a display fault, so no market value appears here. The company has 76 employees, so FGL can reverse in either direction.
Yueda Digital (NASDAQ:YDKG): 13.36% Lower Pre-Market, No Known Trigger
Yueda Digital Holding (NASDAQ:YDKG) was quoted at USD 0.90 before the Tuesday open on November 10, 2026, down 13.36% from a computed prior close of USD 1.0388, a fall of USD 0.1388 per share. Nothing dated November 9 or 10 in the way of releases, filings or analyst notes surfaced across two searches. The prior close is 16.7% above the USD 0.89 close of October 23, computed, a day on which just 11,605 shares changed hands; the pre-market quote surrenders most of that gain. 5.53 million shares imply a computed market value of USD 4.98 million, while a page elsewhere shows USD 4.92 million. The 52-week range runs from USD 0.7307 to USD 8.869. Trailing revenue sits at USD 8.08 million, a 36.7% decline, and the trailing net loss totals USD 86.85 million; headcount is 18. At USD 0.90 the shares sit 10.0% below the USD 1.00 Nasdaq minimum bid, after a 1-for-100 reverse split dated November 10, 2025 and a USD 28 million registered direct offering, leaving dilution a real concern. A few trades can move YDKG.
Oxbridge Re (NASDAQ:OXBR): 11.74% Lower Pre-Market, No Known Trigger
Oxbridge Re (NASDAQ:OXBR) was indicated at USD 0.79 before the Tuesday open on November 10, 2026, down 11.74% from a computed prior close of USD 0.90. Coverage reviewed lists nothing from the company dated November 9 or 10, so the cause of the slide remains unestablished. A quote page from September had USD 1.45 and USD 11.80 million of market value. Simple comparison suggests a fall of about 45% since, though the figures were never squared. Q2 2026 sales came in at USD 940 thousand, against USD 664 thousand in the comparison period; the quarter produced USD 176 thousand of profit compared with a USD 1,873 thousand loss. June 30 cash was USD 4.11 million. With 8,101,374 shares in issue, the computed equity value is around USD 6.4 million, below book equity of USD 6.586 million. The USD 0.79 quote is beneath the USD 1.00 Nasdaq closing-bid threshold: a standing risk, not a reported development. With only 16,851 shares a day on a 20-day average, OXBR could be moved by a few orders.
Where Things Stand
Jin Medical International (NASDAQ:ZJYL) leads the fallers at 17.7%, and none of the five has a trigger dated November 9 or 10 in published coverage. The shared traits are small size, thin trading, sub-USD 1.00 quotes or recent share consolidations, and dilution exposure. Jin Medical International wiped out a full Monday rally. Thinly traded moves can retrace at the open because only a few trades set the quote. This list is built from a pre-market screener reading from November 10, 2026. It is general information and not a recommendation for any investor.






Please wait processing your request...